P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN): RESULTS FROM THE PHASE 3 GLOW STUDY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL

oleh: Arnon Kater, Brandon Hodkinson, Carol Moreno, Talha Munir, Mark-David Levin, Carsten Niemann, Keqin Qi, Pierre Sinet, Kurt Baeten, Donne Bennett Caces, Srimathi Srinivasan